Trials / Completed
CompletedNCT02550574
Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts
Use of 2-octylcyanoacrylate (Dermabond) During Cutaneous Wound Closure With Full-thickness Skin Grafts: a Randomized Split Wound Comparative Effectiveness Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of cutaneous surgery wounds with full-thickness skin grafts improves scar cosmesis compared to wound closure with sutures.
Detailed description
The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of cutaneous surgery wounds with full-thickness skin grafts improves scar cosmesis compared to wound closure with sutures. Our aims are to compare outcomes using a split wound model, where half of the wound is treated with 2-octylcyanoacrylate and the other half is repaired with sutures, per the standard of care. Three-months post-surgery, the scar will be measured via the physician observer scar assessment scale, a validated scar instrument. Our hypothesis is that 2-octylcyanoacrylate will result in cosmetically superior wound outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Wound Closure with 2-octylcyanoacrylate | |
| PROCEDURE | Wound Closure with 5-0 Vicryl Sutures |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-12-01
- Completion
- 2017-05-01
- First posted
- 2015-09-15
- Last updated
- 2017-06-21
Source: ClinicalTrials.gov record NCT02550574. Inclusion in this directory is not an endorsement.